Lilly pauses COVID-19 antibody trial after factory hits trou...

Eli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found serious quality control problems at the plant, according to press reports.

AZ resumes UK coronavirus vaccine trial

AstraZeneca has resumed UK trials for its coronavirus vaccine, after the country's medicines regulator gave the all-clear following a safety scare.

WHO halts hydroxychloroquine trial in COVID-19 following saf...

The World Health Organisation has halted clinical tests of hydroxychloroquine against COVID-19, after safety concerns emerged in a study of medication feted by president Donald Trump as a w

EU regulators warn over safety of Trump's favourite COVID dr...

As the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of chloroquine and its close relative hydroxychloroquine.

Servier to acquire Danish cancer biotech Symphogen

France’s Servier has signed a deal to buy the Danish biotech Symphogen, which specialises in antibody-based therapies for cancer.

FDA says all ranitidine drugs should be recalled on safety c...